Skip to content

Insider · CIK 0001822557

Camilla Simpson V

director

Files at SPRB (SPRUCE BIOSCIENCES, INC.), GRI (GRI Bio, Inc.). First filing -, latest -.

In brief

Camilla Simpson V files SEC Form 4 as director at SPRB (SPRUCE BIOSCIENCES, INC.), and also at GRI (GRI Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Camilla Simpson V has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 16 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 21, 2026SPRB
SPRUCE BIOSCIENCES, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+1,700$0.00$01,700May 26, 2026
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+173--173Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-173--0Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+309--309Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-309--0Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+362--362Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-362--0Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AGrant or award
Stock Option (right to buy)derivative
+133--133Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
DDisposition to issuer
Stock Option (right to buy)derivative
-133--0Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+400--400Dec 15, 2025
Dec 11, 2025SPRB
SPRUCE BIOSCIENCES, INC.
DDisposition to issuer
Stock Option (Right to Buy)derivative
-400--0Dec 15, 2025
Sep 18, 2025GRI
GRI Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+23,605$0.00$023,605Sep 22, 2025
Aug 26, 2025GRI
GRI Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+5,994$0.00$05,994Aug 27, 2025
Aug 13, 2025GRI
GRI Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+4,527$0.00$04,527Aug 14, 2025
Jul 22, 2025SPRB
SPRUCE BIOSCIENCES, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+30,000$0.00$030,000Jul 24, 2025
Jan 23, 2025GRI
GRI Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+30,297$0.69$21k30,297Jan 24, 2025

Questions about Camilla Simpson V

Answered from the filings on this page, as of the latest one.

Is Camilla Simpson V buying or selling?

Camilla Simpson V has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Camilla Simpson V's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Camilla Simpson V has 0.

Where does Camilla Simpson V file Form 4?

Camilla Simpson V has filed Form 4 at SPRB (SPRUCE BIOSCIENCES, INC.); GRI (GRI Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Camilla Simpson V: insider trades and track record | InsiderTell